PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PATIENTS: THE CeTeg/NOA-09 trial Ulrich Herrlinger , Theophilos Tzaridis , Frederic Mack , Joachim Steinbach , Uwe Schlegel , Michael Sabel , Peter Hau , Rolf-Dieter Kortman , Dietmar Krex , Oliver Grauer , Roland Goldbrunner , Oliver Schnell , Oliver Baehr , Martin Uhl , Ghazaleh Tabatabai , Florian Ringel , Friederike Schmidt-Graf , Stefanie Brehmer , Astrid Weyerbrock , Lars Bullinger , Peter Vajkoczy , Hartmut Vatter , Niklas Schaefer , Sied Kebir , Johannes Weller , Walter Stummer , Matthias Simon , Vera Keil , Michael Nelles , Rolf Fimmers , Torsten Pietsch , Elke Hattingen , Christoph Coch , Martin Glas Neuro-oncology(2017)
AI 理解论文
溯源树
样例